Leendert Staal
Leendert Staal
market priority
Our priority now, our aim, is to get 25% market share.
chinese current industry market ourselves platform potential production proteins reaching target tremendous vehicle
We see the potential for a production vehicle with tremendous flexibility, which is a real alternative to Chinese hamster ovaries, the current industry standard. We have set ourselves a target of 25% of all new proteins and monoclonal antibodies. For anything in development and reaching the market between 2015 and 2020, we want 25% of the production platform to be PER.C6.
attractive believe billion choice growing market potential protein rapidly reach technology
The protein market is growing rapidly and may reach $200 billion in 15 to 20 years, and we believe that PER.C6 has the potential to become the technology of choice for an attractive part of that market.